| Acquirer | Target | Price |
|---|---|---|
| Gilead Sciences, Inc. | Global partnership with Galapagos NV | $725 million |
| AstraZeneca plc | Acerta Pharma B.V. | $4 billion |
| AEA Investors LP | 1-800-Contacts, Inc. | N/A |
| PharMerica Corporation | Alternacare Infusion Pharmacy | N/A |
| TeamHealth Holdings, Inc. | Geriatric Essentials | N/A |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
